137 related articles for article (PubMed ID: 35258357)
1. Impact of colchicine on mortality and morbidity in COVID-19: a systematic review.
Sanghavi D; Bansal P; Kaur IP; Mughal MS; Keshavamurthy C; Cusick A; Schram J; Yarrarapu SNS; Giri AR; Kaur N; Moreno Franco P; Abril A; Aslam F
Ann Med; 2022 Dec; 54(1):775-789. PubMed ID: 35258357
[TBL] [Abstract][Full Text] [Related]
2. Can we still consider treatment with colchicine effective in SARS-COV-2 infection? Systematic review, meta-analysis, and trial sequential analysis.
De-Miguel-Balsa E; Estevan-Ortega R; Sempere-Selva MT; Latour-Pérez J; Baeza-Román A; Moya-Martinez A; Ramos-Rincon JM
Eur Rev Med Pharmacol Sci; 2021 Nov; 25(22):7151-7161. PubMed ID: 34859881
[TBL] [Abstract][Full Text] [Related]
3. Safety and efficacy of colchicine in COVID-19 patients: A systematic review and meta-analysis of randomized control trials.
Yasmin F; Najeeb H; Moeed A; Hassan W; Khatri M; Asghar MS; Naveed AK; Ullah W; Surani S
PLoS One; 2022; 17(4):e0266245. PubMed ID: 35381033
[TBL] [Abstract][Full Text] [Related]
4. Ivermectin for preventing and treating COVID-19.
Popp M; Stegemann M; Metzendorf MI; Gould S; Kranke P; Meybohm P; Skoetz N; Weibel S
Cochrane Database Syst Rev; 2021 Jul; 7(7):CD015017. PubMed ID: 34318930
[TBL] [Abstract][Full Text] [Related]
5. Systemic corticosteroids for the treatment of COVID-19.
Wagner C; Griesel M; Mikolajewska A; Mueller A; Nothacker M; Kley K; Metzendorf MI; Fischer AL; Kopp M; Stegemann M; Skoetz N; Fichtner F
Cochrane Database Syst Rev; 2021 Aug; 8(8):CD014963. PubMed ID: 34396514
[TBL] [Abstract][Full Text] [Related]
6. Colchicine treatment can improve outcomes of coronavirus disease 2019 (COVID-19): A systematic review and meta-analysis.
Hariyanto TI; Halim DA; Jodhinata C; Yanto TA; Kurniawan A
Clin Exp Pharmacol Physiol; 2021 Jun; 48(6):823-830. PubMed ID: 33719081
[TBL] [Abstract][Full Text] [Related]
7. Convalescent plasma or hyperimmune immunoglobulin for people with COVID-19: a rapid review.
Valk SJ; Piechotta V; Chai KL; Doree C; Monsef I; Wood EM; Lamikanra A; Kimber C; McQuilten Z; So-Osman C; Estcourt LJ; Skoetz N
Cochrane Database Syst Rev; 2020 May; 5(5):CD013600. PubMed ID: 32406927
[TBL] [Abstract][Full Text] [Related]
8. Colchicine and mortality in patients with coronavirus disease 2019 (COVID-19) pneumonia: A systematic review, meta-analysis, and meta-regression.
Nawangsih EN; Kusmala YY; Rakhmat II; Handayani DR; Juliastuti H; Wibowo A; Lim MA; Pranata R
Int Immunopharmacol; 2021 Jul; 96():107723. PubMed ID: 34162130
[TBL] [Abstract][Full Text] [Related]
9. Effect of colchicine on the outcomes of patients with COVID-19: a systematic review and meta-analysis of randomised controlled trials.
Lan SH; Hsu CK; Lai CC; Chang SP; Lu LC; Hung SH; Lin WT
Ann Med; 2022 Dec; 54(1):1956-1965. PubMed ID: 35833737
[TBL] [Abstract][Full Text] [Related]
10. Oxygen Saturation in Hospitalized COVID-19 Patients and Its Relation to Colchicine Treatment: A Retrospective Cohort Study with an Updated Systematic Review.
Sharaf S; Ashmawy R; Saleh E; Salama M; El-Maradny YA; Zari A; Aly S; Tolba A; Mahrous D; Elsayed H; Latif D; Redwan EM; Kamal E
Medicina (Kaunas); 2023 May; 59(5):. PubMed ID: 37241167
[No Abstract] [Full Text] [Related]
11. Vitamin D supplementation for the treatment of COVID-19: a living systematic review.
Stroehlein JK; Wallqvist J; Iannizzi C; Mikolajewska A; Metzendorf MI; Benstoem C; Meybohm P; Becker M; Skoetz N; Stegemann M; Piechotta V
Cochrane Database Syst Rev; 2021 May; 5(5):CD015043. PubMed ID: 34029377
[TBL] [Abstract][Full Text] [Related]
12. A systematic review of the infectious complications of colchicine and the use of colchicine to treat infections.
McEwan T; Robinson PC
Semin Arthritis Rheum; 2021 Feb; 51(1):101-112. PubMed ID: 33360321
[TBL] [Abstract][Full Text] [Related]
13. Convalescent plasma or hyperimmune immunoglobulin for people with COVID-19: a living systematic review.
Piechotta V; Chai KL; Valk SJ; Doree C; Monsef I; Wood EM; Lamikanra A; Kimber C; McQuilten Z; So-Osman C; Estcourt LJ; Skoetz N
Cochrane Database Syst Rev; 2020 Jul; 7(7):CD013600. PubMed ID: 32648959
[TBL] [Abstract][Full Text] [Related]
14. A Review of the Rational and Current Evidence on Colchicine for COVID-19.
Ghaith HS; Gabra MD; Nafady MH; Elshawah HE; Negida A; Mushtaq G; Kamal MA
Curr Pharm Des; 2022; 28(39):3194-3201. PubMed ID: 34895117
[TBL] [Abstract][Full Text] [Related]
15. Effect of colchicine on mortality in patients with COVID-19 - A systematic review and meta-analysis.
Zein AFMZ; Raffaello WM
Diabetes Metab Syndr; 2022 Feb; 16(2):102395. PubMed ID: 35078098
[TBL] [Abstract][Full Text] [Related]
16. Effect of Colchicine vs Standard Care on Cardiac and Inflammatory Biomarkers and Clinical Outcomes in Patients Hospitalized With Coronavirus Disease 2019: The GRECCO-19 Randomized Clinical Trial.
Deftereos SG; Giannopoulos G; Vrachatis DA; Siasos GD; Giotaki SG; Gargalianos P; Metallidis S; Sianos G; Baltagiannis S; Panagopoulos P; Dolianitis K; Randou E; Syrigos K; Kotanidou A; Koulouris NG; Milionis H; Sipsas N; Gogos C; Tsoukalas G; Olympios CD; Tsagalou E; Migdalis I; Gerakari S; Angelidis C; Alexopoulos D; Davlouros P; Hahalis G; Kanonidis I; Katritsis D; Kolettis T; Manolis AS; Michalis L; Naka KK; Pyrgakis VN; Toutouzas KP; Triposkiadis F; Tsioufis K; Vavouranakis E; Martinèz-Dolz L; Reimers B; Stefanini GG; Cleman M; Goudevenos J; Tsiodras S; Tousoulis D; Iliodromitis E; Mehran R; Dangas G; Stefanadis C;
JAMA Netw Open; 2020 Jun; 3(6):e2013136. PubMed ID: 32579195
[TBL] [Abstract][Full Text] [Related]
17. Colchicine, COVID-19 and hematological parameters: A meta-analysis.
Sarwar M; Ali Z; Fatima M; Sarfraz Z; Sarfraz A; Cherrez-Ojeda I
J Clin Lab Anal; 2021 Dec; 35(12):e24057. PubMed ID: 34708886
[TBL] [Abstract][Full Text] [Related]
18. Colchicine use in patients with COVID-19: A systematic review and meta-analysis.
Chiu L; Lo CH; Shen M; Chiu N; Aggarwal R; Lee J; Choi YG; Lam H; Prsic EH; Chow R; Shin HJ
PLoS One; 2021; 16(12):e0261358. PubMed ID: 34962939
[TBL] [Abstract][Full Text] [Related]
19. Potential Role of Colchicine in Combating COVID-19 Cytokine Storm and Its Ability to Inhibit Protease Enzyme of SARS-CoV-2 as Conferred by Molecular Docking Analysis.
Kamel NA; Ismail NSM; Yahia IS; Aboshanab KM
Medicina (Kaunas); 2021 Dec; 58(1):. PubMed ID: 35056328
[TBL] [Abstract][Full Text] [Related]
20. Colchicine anti-inflammatory therapy for non-intensive care unit hospitalized COVID-19 patients: results from a pilot open-label, randomized controlled clinical trial.
Haroon MZ; Farooq U; Ashraf S; Zeb S; Gillani SY; Malik S; Ali R; Irshad R; Mehmood Z; Abbas Y; Masood A; Ghafoor A; Khalil AT; Asif H; Khan S; Ujjan ID; Nigar R; Livingstone S; Pascual-Figal DA; Togni S; Allergini P; Riva A; Khan A
J Physiol Pharmacol; 2022 Jun; 73(3):. PubMed ID: 36302537
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
